| Year |
Citation |
Score |
| 2022 |
Wong D, Lee TH, Lum A, Tao VL, Yip S. Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma. Acta Neuropathologica Communications. 10: 70. PMID 35526077 DOI: 10.1186/s40478-022-01372-1 |
0.584 |
|
| 2021 |
Levine A, Lee C, Fava C, Tsang F, McNeil K, Yip ST, Hirsch-Reinshagen V. Detailed neuropathologic report of COVID-19 complicated by large intracerebral hemorrhage and periventricular lesions with macrophagic infiltrates. Free Neuropathology. 2. PMID 37284618 DOI: 10.17879/freeneuropathology-2021-3266 |
0.732 |
|
| 2021 |
Boschman J, Farahani H, Darbandsari A, Ahmadvand P, Van Spankeren A, Farnell D, Levine A, Naso JR, Churg A, Jones S, Yip S, Koebel M, Huntsman D, Gilks B, Bashashati A. The utility of color normalization for AI-based diagnosis of hematoxylin and eosin-stained pathology images. The Journal of Pathology. PMID 34543435 DOI: 10.1002/path.5797 |
0.618 |
|
| 2021 |
Marzoughi S, Levine A, Yip S, Chen T. Perivenular Enhancement Without Microbleeds Due to Amyloid Beta-Related Angiitis. The Neurohospitalist. 11: 267-269. PMID 34163556 DOI: 10.1177/1941874420972298 |
0.567 |
|
| 2021 |
Naso JR, Levine AB, Farahani H, Chirieac LR, Dacic S, Wright JL, Lai C, Yang HM, Jones SJM, Bashashati A, Yip S, Churg A. Deep-learning based classification distinguishes sarcomatoid malignant mesotheliomas from benign spindle cell mesothelial proliferations. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 34112957 DOI: 10.1038/s41379-021-00850-6 |
0.628 |
|
| 2021 |
Britton HM, Levine AB, Shen Y, Mungall K, Serrano J, Snuderl M, Pleasance E, Jones SJM, Laskin J, Marra MA, Rassekh SR, Deyell R, Yip S, Cheng S, Dunham C. NTRK2 Fusion driven pediatric glioblastoma: Identification of oncogenic Drivers via integrative Genome and transcriptome profiling. Clinical Case Reports. 9: 1472-1477. PMID 33768871 DOI: 10.1002/ccr3.3804 |
0.647 |
|
| 2020 |
Dixon K, Young S, Shen Y, Thibodeau ML, Fok A, Pleasance E, Zhao E, Jones M, Aubert G, Armstrong L, Virani A, Regier D, Gelmon K, Renouf D, Chia S, ... ... Yip S, et al. Establishing a Framework for the Clinical Translation of Germline Findings in Precision Oncology. Jnci Cancer Spectrum. 4: pkaa045. PMID 33134827 DOI: 10.1093/Jncics/Pkaa045 |
0.399 |
|
| 2020 |
Wong D, Sogerer L, Lee SS, Wong V, Lum A, Levine AB, Marra MA, Yip S. TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L. Bmc Biology. 18: 154. PMID 33115448 DOI: 10.1186/s12915-020-00895-0 |
0.714 |
|
| 2020 |
Levine AB, Wong D, Fatehi M, Yip S. Ependymoma and Chordoma. Neurosurgery. 87: 860-870. PMID 33057707 DOI: 10.1093/neuros/nyaa329 |
0.739 |
|
| 2020 |
Levine AB, Peng J, Farnell D, Nursey M, Wang Y, Naso JR, Ren H, Farahani H, Chen C, Chiu D, Talhouk A, Sheffield B, Riazy M, Ip PP, Parra-Herran C, ... ... Yip S, et al. Synthesis of diagnostic quality cancer pathology images by generative adversarial networks. The Journal of Pathology. PMID 32686118 DOI: 10.1002/Path.5509 |
0.646 |
|
| 2020 |
Zou Y, Turashvili G, Soslow RA, Park KJ, Croce S, McCluggage WG, Stewart CJR, Oda Y, Oliva E, Young RH, Da Cruz Paula A, Dessources K, Ashley CW, Hensley ML, Yip S, et al. High-grade transformation of low-grade endometrial stromal sarcomas lacking YWHAE and BCOR genetic abnormalities. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 32317704 DOI: 10.1038/S41379-020-0535-Y |
0.332 |
|
| 2020 |
Wong D, Yip S. Making heads or tails - The emergence of capicua (CIC) as an important multifunctional tumour suppressor. The Journal of Pathology. PMID 32073140 DOI: 10.1002/Path.5400 |
0.619 |
|
| 2019 |
Mohammad N, Wong D, Lum A, Lin J, Ho J, Lee CH, Yip S. Characterization of IDH1/IDH2 Mutation and D-2-Hydroxyglutarate Oncometabolite Level in Dedifferentiated Chondrosarcoma. Histopathology. PMID 31609487 DOI: 10.1111/His.14018 |
0.579 |
|
| 2019 |
Wong D, Yip S. Finding a four-leaf clover - identifying long term survivors in IDH- wildtype glioblastoma. Neuro-Oncology. PMID 31511900 DOI: 10.1093/Neuonc/Noz174 |
0.556 |
|
| 2019 |
Ghasemi DR, Sill M, Okonechnikov K, Korshunov A, Yip S, Schutz PW, Scheie D, Kruse A, Harter PN, Kastelan M, Wagner M, Hartmann C, Benzel J, Maass KK, Khasraw M, et al. MYCN amplification drives an aggressive form of spinal ependymoma. Acta Neuropathologica. PMID 31414211 DOI: 10.1007/S00401-019-02056-2 |
0.767 |
|
| 2019 |
Wong D, Shen Y, Levine AB, Pleasance E, Jones M, Mungall K, Thiessen B, Toyota B, Laskin J, Jones SJM, Marra MA, Yip S. The pivotal role of sampling recurrent tumors in the precision care of patients with tumors of the central nervous system. Cold Spring Harbor Molecular Case Studies. 5. PMID 31371350 DOI: 10.1101/mcs.a004143 |
0.747 |
|
| 2019 |
Wong D, Yip S, Sorensen PH. Methods for Identifying Patients with Tropomyosin Receptor Kinase (TRK) Fusion Cancer. Pathology Oncology Research : Por. PMID 31256325 DOI: 10.1007/S12253-019-00685-2 |
0.608 |
|
| 2019 |
Lee CH, Kao YC, Lee WR, Hsiao YW, Lu TP, Chu CY, Lin YJ, Huang HY, Hsieh TH, Liu YR, Liang CW, Chen TW, Yip S, Lum A, Kuo KT, et al. Clinicopathologic Characterization of GREB1-rearranged Uterine Sarcomas With Variable Sex-Cord Differentiation. The American Journal of Surgical Pathology. PMID 31094921 DOI: 10.1097/Pas.0000000000001265 |
0.347 |
|
| 2019 |
Jones MR, Williamson LM, Topham JT, Lee MK, Goytain A, Ho J, Denroche RE, Jang GH, Pleasance ED, Shen Y, Karasinska JM, McGhie JP, Gill S, Lim H, Moore MJ, ... ... Yip S, et al. NRG1 gene fusions are recurrent, clinically actionable gene rearrangements in KRAS wild-type pancreatic ductal adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31068372 DOI: 10.1158/1078-0432.Ccr-19-0191 |
0.318 |
|
| 2019 |
Bettegowda C, Yip S, Jiang B, Wang WL, Clarke MJ, Lazary A, Gambarotti M, Zhang M, Sciubba DM, Wolinsky JP, Goodwin CR, McCarthy E, Germscheid NM, Sahgal A, Gokaslan ZL, et al. Prognostic significance of hTERT (human telomerase reverse transcriptase) promoter region mutations C228T and C250T for overall survival in spinal chordomas. Neuro-Oncology. PMID 30976795 DOI: 10.1093/Neuonc/Noz066 |
0.302 |
|
| 2019 |
Levine AB, Schlosser C, Grewal J, Coope R, Jones SJM, Yip S. Rise of the Machines: Advances in Deep Learning for Cancer Diagnosis. Trends in Cancer. 5: 157-169. PMID 30898263 DOI: 10.1016/J.Trecan.2019.02.002 |
0.648 |
|
| 2019 |
Pender A, Karsan A, Yip S, Bosdet I, Young S, Tucker T, Schrader KA, Sun S. Confirmation of germline variants identified by tumor testing: A population-based study. Journal of Clinical Oncology. 37: e13021-e13021. DOI: 10.1200/Jco.2019.37.15_Suppl.E13021 |
0.36 |
|
| 2019 |
Pender A, Hughesman C, Law E, Kristanti A, McNeil K, Tucker T, Bosdet I, Young S, Laskin JJ, Karsan A, Yip S, Ho C. Quantification of circulating free and circulating tumor DNA in pretreated EGFR mutant NSCLC to inform patient outcomes. Journal of Clinical Oncology. 37: 9080-9080. DOI: 10.1200/Jco.2019.37.15_Suppl.9080 |
0.301 |
|
| 2019 |
Zhao EY, Feng X, Pleasance ED, Ng TL, Grewal J, Mohammad N, Taylor SK, Simmons CE, Srikanthan A, Rassekh SR, Deyell R, Shen Y, Titmuss E, Lim HJ, Renouf DJ, ... ... Yip S, et al. The whole genome landscape of adult metastatic sarcoma. Journal of Clinical Oncology. 37: 3137-3137. DOI: 10.1200/Jco.2019.37.15_Suppl.3137 |
0.33 |
|
| 2019 |
Pender A, Titmuss E, Pleasance E, Fan K, Pearson H, Bonakdar M, Taylor G, Mungall K, Moore R, Lavoie J-, Yip S, Lim H, Renouf D, Jones SJ, Marra MA, et al. Predictive markers of checkpoint inhibitor activity in adult metastatic solid tumours Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz253.081 |
0.309 |
|
| 2018 |
Liu SL, Loree J, Renouf D, Jones M, Yip S, Marra M, Jones S, Nelson J, Laskin J, Lim H, Gill S. Clinical benefit of whole genome and transcriptome analysis (WGTA) in metastatic colorectal cancer (MCRC): Results from the personalized oncogenomics program (POG). Annals of Oncology : Official Journal of the European Society For Medical Oncology. 29: viii195. PMID 32136392 DOI: 10.1093/Annonc/Mdy281.131 |
0.304 |
|
| 2018 |
Wong D, Yip S. Machine learning classifies cancer. Nature. 555: 446-447. PMID 32034348 DOI: 10.1038/D41586-018-02881-7 |
0.585 |
|
| 2018 |
Tsang ES, Shen Y, Chooback N, Ho C, Jones M, Renouf DJ, Lim H, Sun S, Yip S, Pleasance E, Ionescu DN, Mungall K, Kasaian K, Ma Y, Zhao Y, et al. Clinical Outcomes after Whole Genome Sequencing in Patients with Metastatic Non-Small Cell Lung Cancer. Cold Spring Harbor Molecular Case Studies. PMID 30514790 DOI: 10.1101/mcs.a002659 |
0.332 |
|
| 2018 |
Dickson BC, Lum A, Swanson D, Bernardini MQ, Colgan TJ, Shaw PA, Yip S, Lee CH. Novel EPC1 gene fusions in endometrial stromal sarcoma. Genes, Chromosomes & Cancer. PMID 30144186 DOI: 10.1002/Gcc.22649 |
0.351 |
|
| 2018 |
Wong D, Lounsbury K, Lum A, Song J, Chan S, LeBlanc V, Chittaranjan S, Marra M, Yip S. Transcriptomic analysis of CIC and ATXN1L reveal a functional relationship exploited by cancer. Oncogene. PMID 30093628 DOI: 10.1038/S41388-018-0427-5 |
0.612 |
|
| 2018 |
Wong D, Yip S. Machine learning classifies cancer. Nature. 555: 446-447. PMID 29565394 DOI: 10.1038/d41586-018-02881-7 |
0.52 |
|
| 2018 |
Liu KYP, Lu XJD, Zhu Y, Yip S, Poh CF. Altered Immune-Related Gene Expressions Indicate Oral Cancer Nodal Disease. Journal of Dental Research. 22034518758045. PMID 29489424 DOI: 10.1177/0022034518758045 |
0.314 |
|
| 2018 |
Li V, Levine AB, Gooderham PA, Yip S, Chew J. A case of primary central nervous system lymphoma arising at the site of remote herpes encephalitis. World Neurosurgery. PMID 29382621 DOI: 10.1016/J.Wneu.2018.01.143 |
0.647 |
|
| 2018 |
Lim HJ, Schrader KA, Young S, Nelson JMT, Fok A, Pleasance E, Jones M, Shen Y, Armstrong L, Virani A, Rassekh S, Deyell R, Yip S, Roscoe R, Karsan A, et al. Abstract A190: Management of germline findings revealed throughout the course of tumor-normal whole genome sequencing in oncology Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-A190 |
0.384 |
|
| 2018 |
Shen Y, Jones MR, Pleasance E, Bonakdar M, Ch'ng C, Reisle C, Williamson L, Majounie E, Taylor G, Chan S, Pierce B, Zhang W, Muhammadzadeh A, Zhao EY, Bleile D, ... ... Yip S, et al. Abstract A184: Clinical application of whole genome and transcriptome sequencing in cancer care Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-A184 |
0.397 |
|
| 2017 |
Alvarez-Breckenridge C, Miller JJ, Nayyar N, Gill CM, Kaneb A, D'Andrea M, Le LP, Lee J, Cheng J, Zheng Z, Butler WE, Multani P, Chow Maneval E, Ha Paek S, Toyota BD, ... ... Yip S, et al. Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor. Npj Precision Oncology. 1: 5. PMID 29872694 DOI: 10.1038/s41698-017-0009-y |
0.482 |
|
| 2017 |
Zhao EY, Shen Y, Pleasance E, Kasaian K, Leelakumari S, Jones M, Bose P, Ch'ng C, Reisle C, Eirew P, Corbett R, Mungall KL, Thiessen N, Ma Y, Schein JE, ... ... Yip S, et al. Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 23: 7521-7530. PMID 29246904 DOI: 10.1158/1078-0432.Ccr-17-1941 |
0.347 |
|
| 2017 |
Tarpey PS, Behjati S, Young MD, Martincorena I, Alexandrov LB, Farndon SJ, Guzzo C, Hardy C, Latimer C, Butler AP, Teague JW, Shlien A, Futreal PA, Shah S, Bashashati A, ... ... Yip S, et al. The driver landscape of sporadic chordoma. Nature Communications. 8: 890. PMID 29026114 DOI: 10.1038/S41467-017-01026-0 |
0.321 |
|
| 2017 |
Jones MR, Lim H, Shen Y, Pleasance E, Ch'ng C, Reisle C, Leelakumari S, Zhao C, Yip S, Ho J, Zhong E, Ng T, Ionescu D, Schaeffer DF, Mungall AJ, et al. Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 28950338 DOI: 10.1093/Annonc/Mdx523 |
0.353 |
|
| 2017 |
Panwalkar P, Clark J, Ramaswamy V, Hawes D, Yang F, Dunham C, Yip S, Hukin J, Sun Y, Schipper MJ, Chavez L, Margol A, Pekmezci M, Chung C, Banda A, et al. Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome. Acta Neuropathologica. PMID 28733933 DOI: 10.1007/S00401-017-1752-4 |
0.346 |
|
| 2017 |
LeBlanc VG, Firme M, Song J, Chan SY, Lee MH, Yip S, Chittaranjan S, Marra MA. Comparative transcriptome analysis of isogenic cell line models and primary cancers links CIC loss to activation of the MAPK signalling cascade. The Journal of Pathology. PMID 28295365 DOI: 10.1002/Path.4894 |
0.332 |
|
| 2017 |
Chooback N, Ho C, Shen Y, Tsang ES, Zhao Y, Mungall AJ, Moore R, Lim HJ, Renouf DJ, Gelmon KA, Yip S, Jones S, Laskin JJ, Marra M. Whole genome and transcriptome sequencing of lung cancer: Options for personalized cancer treatment. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E20567 |
0.311 |
|
| 2017 |
Lim HJ, Schrader KA, Young S, Nelson J, Fok A, Pleasance E, Jones M, Shen Y, Armstrong L, Virani A, Rassekh SR, Deyell R, Yip S, Roscoe R, Karsan A, et al. Management of germline findings revealed throughout the course of tumor-normal whole genome sequencing in oncology. Journal of Clinical Oncology. 35: e13113-e13113. DOI: 10.1200/Jco.2017.35.15_Suppl.E13113 |
0.373 |
|
| 2017 |
Wong D, Lounsbury K, LeBlanc V, Chittaranjan S, Marra M, Yip S. Csig-12. Exploring The Functional Relationship Between Capicua (Cic) And Ataxin-1-Like (Atxn1L) In Glioma Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.207 |
0.624 |
|
| 2017 |
Brastianos PK, Alvarez-Breckenridge C, Miller JJ, Nayyar N, Gill C, Dias-Santagata D, Santagata S, Multani P, Yip S, Cahill D, Iafrate AJ, Batchelor T. OS06.4 Identification of novel NTRK fusion in glioneuronal tumors and radiographic response following therapy with an NTRK inhibitor Neuro-Oncology. 19: iii11-iii11. DOI: 10.1093/Neuonc/Nox036.038 |
0.486 |
|
| 2017 |
Wong D, LeBlanc V, Chittaranjan S, Chan S, Song J, Lee M, Marra M, Yip S. A.04 Functional investigations of CIC and ATXN1L in Oligodendroglioma Canadian Journal of Neurological Sciences. 44. DOI: 10.1017/Cjn.2017.68 |
0.534 |
|
| 2017 |
Wong D, Leblanc V, Chittaranjan S, Marra M, Yip S. Investigations of the functional interactions between CIC and ATXN1L in Oligodendroglioma Canadian Journal of Neurological Sciences. 44. DOI: 10.1017/Cjn.2017.2 |
0.534 |
|
| 2016 |
Torchia J, Golbourn B, Feng S, Ho KC, Sin-Chan P, Vasiljevic A, Norman JD, Guilhamon P, Garzia L, Agamez NR, Lu M, Chan TS, Picard D, de Antonellis P, Khuong-Quang DA, ... ... Yip S, et al. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors. Cancer Cell. 30: 891-908. PMID 27960086 DOI: 10.1016/J.Ccell.2016.11.003 |
0.367 |
|
| 2016 |
Derakhshan F, Taraboanta C, Yip S. Epstein-Barr virus associated primary intracranial leiomyoma in a patient with human immunodeficiency virus. Clinical Neuropathology. PMID 27841145 DOI: 10.5414/Np300987 |
0.312 |
|
| 2016 |
Alassiri AH, Ali RH, Shen Y, Lum A, Strahlendorf C, Deyell R, Rassekh R, Sorensen PH, Laskin J, Marra M, Yip S, Lee CH, Ng TL. ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors. The American Journal of Surgical Pathology. PMID 27259007 DOI: 10.1097/Pas.0000000000000677 |
0.37 |
|
| 2016 |
Jones MR, Schrader KA, Shen Y, Pleasance E, Ch'ng C, Dar N, Yip S, Renouf DJ, Schein JE, Mungall AJ, Zhao Y, Moore R, Ma Y, Sheffield BS, Ng T, et al. Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. PMID 27022066 DOI: 10.1093/Annonc/Mdw060 |
0.311 |
|
| 2016 |
Wong H, Jones M, Eirew P, Karasinska J, Schrader KA, Lim HJ, Shen Y, Jones S, Yip S, Laskin JJ, Marra M, Schaeffer DF, Renouf DJ. Comprehensive genomic analysis in metastatic pancreatic ductal adenocarcinoma (PDAC). Journal of Clinical Oncology. 34: 285-285. DOI: 10.1200/Jco.2016.34.4_Suppl.285 |
0.4 |
|
| 2016 |
Bose P, Pleasance E, Jones M, Shen Y, Ch'ng C, Reisle C, Schein JE, Mungall A, Moore R, Ma Y, Sheffield BS, Thomson T, Rasmussen S, Lee C, Yip S, et al. Abstract PR02: Integrated genomic analysis of a recurrent ghost cell odontogenic carcinoma Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pmsclingen15-Pr02 |
0.386 |
|
| 2016 |
Morozova O, Newton Y, Cline M, Yip S, Rao A, Stuart J, Goldstein T, Salama S, Deyell R, Rassekh SR, Haussler D. Abstract PR14: Harnessing the power of big data to advance pediatric cancer care Cancer Research. 76. DOI: 10.1158/1538-7445.Pedca15-Pr14 |
0.358 |
|
| 2016 |
Wong H, Karasinska JM, Jones M, Eirew P, Schrader K, Lim H, Shen Y, Jones S, Yip S, Laskin J, Marra M, Schaeffer DF, Renouf DJ. Abstract B81: Gene expression analysis demonstrates prognostic subtypes in metastatic pancreatic ductal adenocarcinoma (PDAC) Cancer Research. 76. DOI: 10.1158/1538-7445.Panca16-B81 |
0.375 |
|
| 2016 |
Schrader KA, Chu’ng C, Zhao E, Wong H, Shen Y, Jones M, Thomson T, Lim H, Young S, Cremin C, Holt R, Eirew P, Karasinska J, Schein J, Zhao Y, ... ... Yip S, et al. Abstract 5226: Genomic analysis of pancreatic ductal adenocarcinoma in a patient with MUTYH-associated polyposis Cancer Research. 76: 5226-5226. DOI: 10.1158/1538-7445.Am2016-5226 |
0.375 |
|
| 2016 |
Laskin JJ, Shen Y, Renouf D, Jones M, Lim H, Fok A, Ho C, Deol B, Gelmon KA, Chia S, Moore R, Mungall A, Yip S, Jones S, Marra M. Abstract 2631: Restrictions on access to systemic therapy limit the application of whole genome sequencing in clinical care Cancer Research. 76: 2631-2631. DOI: 10.1158/1538-7445.Am2016-2631 |
0.346 |
|
| 2016 |
Laskin J, Ho C, Shen Y, Jones M, Gelmon KA, Lim H, Renouf DJ, Yip S, Tinker A, Khoo K, Lohrisch C, Chia S, Deol B, Schrader K, Ma Y, et al. Availability of tumour gene expression data facilitates clinical decision-making for patients with advanced cancers Annals of Oncology. 27. DOI: 10.1093/Annonc/Mdw392.01 |
0.301 |
|
| 2015 |
Platt MY, Fathi AT, Borger DR, Brunner AM, Hasserjian RP, Balaj L, Lum A, Yip S, Dias-Santagata D, Zheng Z, Le LP, Graubert TA, Iafrate AJ, Nardi V. Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic Syndromes. The Journal of Molecular Diagnostics : Jmd. PMID 26331834 DOI: 10.1016/J.Jmoldx.2015.06.004 |
0.305 |
|
| 2015 |
Irving JA, Lee CH, Yip S, Oliva E, McCluggage WG, Young RH. Microcystic Stromal Tumor: A Distinctive Ovarian Sex Cord-Stromal Neoplasm Characterized by FOXL2, SF-1, WT-1, Cyclin D1, and β-catenin Nuclear Expression and CTNNB1 Mutations. The American Journal of Surgical Pathology. PMID 26200099 DOI: 10.1097/Pas.0000000000000482 |
0.319 |
|
| 2015 |
Schutz PW, Honey CR, Yip S. 35-Year-Old Man with Lytic Skull Lesion. Langerhans Cell Histiocytosis (LCH). Brain Pathology (Zurich, Switzerland). 25: 367-8. PMID 26086055 DOI: 10.1111/Bpa.12258 |
0.718 |
|
| 2015 |
Torchia J, Picard D, Lafay-Cousin L, Hawkins CE, Kim SK, Letourneau L, Ra YS, Ho KC, Chan TS, Sin-Chan P, Dunham CP, Yip S, Ng HK, Lu JQ, Albrecht S, et al. Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis. The Lancet. Oncology. 16: 569-82. PMID 25882982 DOI: 10.1016/S1470-2045(15)70114-2 |
0.329 |
|
| 2015 |
Sheffield BS, Tinker AV, Shen Y, Hwang H, Li-Chang HH, Pleasance E, Ch'ng C, Lum A, Lorette J, McConnell YJ, Sun S, Jones SJ, Gown AM, Huntsman DG, Schaeffer DF, ... ... Yip S, et al. Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing. Plos One. 10: e0119689. PMID 25798586 DOI: 10.1371/Journal.Pone.0119689 |
0.349 |
|
| 2015 |
Li-Chang HH, Kasaian K, Ng Y, Lum A, Kong E, Lim H, Jones SJ, Huntsman DG, Schaeffer DF, Yip S. Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas. Bmc Cancer. 15: 32. PMID 25656989 DOI: 10.1186/S12885-015-1021-7 |
0.323 |
|
| 2015 |
Di Stefano AL, Fucci A, Frattini V, Labussiere M, Mokhtari K, Zoppoli P, Marie Y, Bruno A, Boisselier B, Giry M, Savatovsky J, Touat M, Belaid H, Kamoun A, Idbaih A, ... ... Yip S, et al. Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 3307-17. PMID 25609060 DOI: 10.1158/1078-0432.Ccr-14-2199 |
0.309 |
|
| 2015 |
Li AM, Dunham C, Tabori U, Carret AS, McNeely PD, Johnston D, Lafay-Cousin L, Wilson B, Eisenstat DD, Jabado N, Zelcer S, Silva M, Scheinemann K, Fryer C, Hendson G, ... ... Yip S, et al. EZH2 expression is a prognostic factor in childhood intracranial ependymoma: a Canadian Pediatric Brain Tumor Consortium study. Cancer. 121: 1499-507. PMID 25586788 DOI: 10.1002/Cncr.29198 |
0.33 |
|
| 2015 |
Sun S, Gelmon KA, Chia S, Lohrisch C, Shenkier T, Villa D, Shen Y, Jones M, Pleasance E, Kasaian K, Eirew P, Leelakumari S, Ma Y, Ng T, Yip S, et al. Abstract 1122: Personalized oncogenomics in advanced stage breast cancer Cancer Research. 75: 1122-1122. DOI: 10.1158/1538-7445.Am2015-1122 |
0.36 |
|
| 2015 |
Lim H, Schrader K, Young S, Fok A, Pleasance E, Jones M, Shen Y, Armstrong L, Virani A, Rassekh S, Deyell R, Yip S, Roscoe R, Karsan A, Marra M, et al. 232 Management of germline findings revealed throughout the course of tumor-normal whole genome sequencing in oncology European Journal of Cancer. 51: S37-S38. DOI: 10.1016/S0959-8049(16)30119-8 |
0.316 |
|
| 2015 |
Lim H, Renouf D, Sun S, Ho C, Gelmon K, Chia S, Pleasance E, Jones M, Shen Y, Eirew P, Rassekh S, Deyell R, Yip S, Huntsman D, Roscoe R, et al. 231 Whole genome analysis in a population-based cancer system: Results from sequencing >100 metastatic cancer patients European Journal of Cancer. 51. DOI: 10.1016/S0959-8049(16)30118-6 |
0.315 |
|
| 2014 |
Laskin J, Moore R, Shen Y, Lim H, Gelmon KA, Renouf D, Yip S, Huntsman D, Ng T, Mungall A, Fok A, Ho C, Chia S, Leelakumari S, Kasaian K, et al. 1570ODEMONSTRATION OF TEMPORAL HETEROGENEITY IDENTIFIED BY GENOME SEQUENCING AND THE POTENTIAL EFFECT ON TREATMENT DECISIONS FOR ADVANCED CANCER PATIENTS. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 25: iv546. PMID 28172072 DOI: 10.1093/Annonc/Mdu358.1 |
0.358 |
|
| 2014 |
Tone AA, McConechy MK, Yang W, Ding J, Yip S, Kong E, Wong KK, Gershenson DM, Mackay H, Shah S, Gilks B, Tinker AV, Clarke B, McAlpine JN, Huntsman D. Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas. Bmc Cancer. 14: 982. PMID 25523272 DOI: 10.1186/1471-2407-14-982 |
0.346 |
|
| 2014 |
Shih F, Yip S, McDonald PJ, Chudley AE, Del Bigio MR. Oncogenic codon 13 NRAS mutation in a primary mesenchymal brain neoplasm and nevus of a child with neurocutaneous melanosis. Acta Neuropathologica Communications. 2: 140. PMID 25330907 DOI: 10.1186/S40478-014-0140-8 |
0.325 |
|
| 2014 |
Jamshidi F, Pleasance E, Li Y, Shen Y, Kasaian K, Corbett R, Eirew P, Lum A, Pandoh P, Zhao Y, Schein JE, Moore RA, Rassekh R, Huntsman DG, Knowling M, ... ... Yip S, et al. Diagnostic value of next-generation sequencing in an unusual sphenoid tumor. The Oncologist. 19: 623-30. PMID 24807916 DOI: 10.1634/Theoncologist.2013-0390 |
0.401 |
|
| 2014 |
Taylor KR, Mackay A, Truffaux N, Butterfield YS, Morozova O, Philippe C, Castel D, Grasso CS, Vinci M, Carvalho D, Carcaboso AM, de Torres C, Cruz O, Mora J, Entz-Werle N, ... ... Yip S, et al. Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nature Genetics. 46: 457-61. PMID 24705252 DOI: 10.1038/Ng.2925 |
0.339 |
|
| 2014 |
Huse JT, Wallace M, Aldape KD, Berger MS, Bettegowda C, Brat DJ, Cahill DP, Cloughesy T, Haas-Kogan DA, Marra M, Miller CR, Nelson SJ, Salama SR, Soffietti R, Wen PY, ... Yip S, et al. Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshop. Neuro-Oncology. 16: 173-8. PMID 24305708 DOI: 10.1093/Neuonc/Not229 |
0.519 |
|
| 2014 |
Lee CH, Hoang LN, Yip S, Reyes C, Marino-Enriquez A, Eilers G, Tao D, Chiang S, Fletcher JA, Soslow RA, Nucci MR, Oliva E. Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 27: 751-7. PMID 24186140 DOI: 10.1038/Modpathol.2013.199 |
0.352 |
|
| 2014 |
Baxter SD, Lim HJ, Shen Y, Laskin JJ, Renouf DJ, Yip S, Huntsman D, Chia SKL, Li Y, Kasaian K, Eirew P, Leelakumari S, Ma Y, Aparicio S, Jones S, et al. Whole-genome DNA and RNA sequencing in patients with metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.E22078 |
0.351 |
|
| 2014 |
Kasaian K, Shen Y, Leelakumari S, Eirew P, Li YY, Pleasance E, Corbett R, Mungall KL, Schein J, Mungall AJ, Zhao Y, Moore RA, Yip S, Gelmon K, Lim H, et al. Abstract 5340: Bioinformatic analyses approaches for personalized oncogenomics Cancer Research. 74: 5340-5340. DOI: 10.1158/1538-7445.Am2014-5340 |
0.4 |
|
| 2014 |
Varga P, Fisher C, Rhines L, Gokaslan Z, Boriani S, Lazary Á, Wang W, Germscheid N, Yip S, Bettegowda C. Abstract 4704: Prognostic significance of T gene SNP s2305089 in individuals with spinal column chordoma Cancer Research. 74: 4704-4704. DOI: 10.1158/1538-7445.Am2014-4704 |
0.303 |
|
| 2014 |
Laskin JJ, Shen Y, Lim H, Gelmon KA, Renouf D, Yip S, Huntsman D, Tinker A, Ho C, Chia S, Li Y, Kasaian K, Eirew P, Leelakumari S, Moore R, et al. Abstract 4283: Whole genome sequencing is superior to cancer panels to aid in decision-making in patients with advanced malignancies Cancer Research. 74: 4283-4283. DOI: 10.1158/1538-7445.Am2014-4283 |
0.376 |
|
| 2013 |
Triscott J, Lee C, Foster C, Manoranjan B, Pambid MR, Berns R, Fotovati A, Venugopal C, O'Halloran K, Narendran A, Hawkins C, Ramaswamy V, Bouffet E, Taylor MD, Singhal A, ... ... Yip S, et al. Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children. Cancer Research. 73: 6734-44. PMID 24019381 DOI: 10.1158/0008-5472.Can-12-4331 |
0.329 |
|
| 2013 |
Bashashati A, Ha G, Tone A, Ding J, Prentice LM, Roth A, Rosner J, Shumansky K, Kalloger S, Senz J, Yang W, McConechy M, Melnyk N, Anglesio M, Luk MT, ... ... Yip S, et al. Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling. The Journal of Pathology. 231: 21-34. PMID 23780408 DOI: 10.1002/Path.4230 |
0.361 |
|
| 2013 |
Snuderl M, Batista A, Kirkpatrick ND, Ruiz de Almodovar C, Riedemann L, Walsh EC, Anolik R, Huang Y, Martin JD, Kamoun W, Knevels E, Schmidt T, Farrar CT, Vakoc BJ, Mohan N, ... ... Yip S, et al. Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma. Cell. 152: 1065-76. PMID 23452854 DOI: 10.1016/J.Cell.2013.01.036 |
0.334 |
|
| 2013 |
Mohapatra G, Sharma J, Yip S. Array CGH in brain tumors. Methods in Molecular Biology (Clifton, N.J.). 973: 325-38. PMID 23412799 DOI: 10.1007/978-1-62703-281-0_20 |
0.351 |
|
| 2013 |
Peixoto RD, Li Y, Pleasance E, Yip S, Zhao Y, Schein J, Shen Y, Lim HJ, Renouf DJ, Gelmon KA, Huntsman D, Jones S, Marra M, Laskin JJ. A case of the utilization of genomic information in the management of metastatic colorectal cancer. Journal of Clinical Oncology. 31: 444-444. DOI: 10.1200/Jco.2013.31.4_Suppl.444 |
0.334 |
|
| 2013 |
Lim HJ, Kollmannsberger CK, Gill S, Kong E, Ng Y, Lum A, Woo M, Huntsman D, Yip S. Results from Ion AmpiSeq Cancer Panel in 200 cases of gastric and gastroesophageal junction cancer. Journal of Clinical Oncology. 31: 39-39. DOI: 10.1200/Jco.2013.31.4_Suppl.39 |
0.334 |
|
| 2013 |
Laskin JJ, Lim HJ, Gelmon KA, Ho C, Renouf DJ, Yip S, Huntsman D, Tinker A, Pleasance E, Li Y, Shen Y, Kasaian K, Corbett R, Mungall K, Mungall A, et al. Practical application of whole genome and transcriptome tumour analysis to guide chemotherapy decision-making for patients with advanced cancers. Journal of Clinical Oncology. 31. DOI: 10.1200/Jco.2013.31.15_Suppl.E22020 |
0.348 |
|
| 2013 |
Laskin JJ, Gelmon K, Lim H, Renouf D, Yip S, Huntsman D, Tinker A, Ho C, Pleasance ED, Li Y, Shen Y, Kasaian K, Corbett R, Mungall K, Zhao Y, et al. Abstract LB-173: Genome analysis informs chemotherapy decision-making in patients with advanced malignancies. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-173 |
0.382 |
|
| 2013 |
Yip S, Miao J, Cahill DP, Iafrate AJ, Aldape KD, Nutt CL. Erratum: MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance (Clinical Cancer Research (2009) 15 (4622-4629)) Clinical Cancer Research. 19: 4543-4544. DOI: 10.1158/1078-0432.Ccr-13-1821 |
0.306 |
|
| 2013 |
Gurung A, Yip S, Kennecke H, Zhou C. Mucinous Response Following Preoperative Bevacizumab, Capecitabine, Oxaliplatin, and Radiation is a Diagnostic Pitfall in Assessment of Tumor Type, Regression Grade, and Stage in Patients With Locally Advanced Low Rectal Cancer American Journal of Clinical Pathology. 140. DOI: 10.1093/Ajcp/140.Suppl1.027 |
0.343 |
|
| 2012 |
Yang MM, Singhal A, Rassekh SR, Yip S, Eydoux P, Dunham C. Possible differentiation of cerebral glioblastoma into pleomorphic xanthoastrocytoma: an unusual case in an infant. Journal of Neurosurgery. Pediatrics. 9: 517-23. PMID 22546030 DOI: 10.3171/2012.1.Peds11326 |
0.34 |
|
| 2012 |
Lee C, Fotovati A, Triscott J, Chen J, Venugopal C, Singhal A, Dunham C, Kerr JM, Verreault M, Yip S, Wakimoto H, Jones C, Jayanthan A, Narendran A, Singh SK, et al. Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice. Stem Cells (Dayton, Ohio). 30: 1064-75. PMID 22415968 DOI: 10.1002/Stem.1081 |
0.346 |
|
| 2012 |
Lee C, Dunn SE, Yip S. Stem cells in brain tumour development and therapy- two-sides of the same coin. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 39: 145-56. PMID 22343146 DOI: 10.1017/S0317167100013159 |
0.314 |
|
| 2012 |
Fleming AJ, Hukin J, Rassekh R, Fryer C, Kim J, Stemmer-Rachamimov A, Birks DK, Huang A, Yip S, Dunham C. Atypical teratoid rhabdoid tumors (ATRTs): the British Columbia's Children's Hospital's experience, 1986-2006. Brain Pathology (Zurich, Switzerland). 22: 625-35. PMID 22188464 DOI: 10.1111/J.1750-3639.2011.00561.X |
0.58 |
|
| 2012 |
Kanai R, Rabkin SD, Yip S, Sgubin D, Zaupa CM, Hirose Y, Louis DN, Wakimoto H, Martuza RL. Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells. Journal of the National Cancer Institute. 104: 42-55. PMID 22173583 DOI: 10.1093/Jnci/Djr509 |
0.483 |
|
| 2012 |
Yip S, Butterfield YS, Morozova O, Chittaranjan S, Blough MD, An J, Birol I, Chesnelong C, Chiu R, Chuah E, Corbett R, Docking R, Firme M, Hirst M, Jackman S, et al. Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers. The Journal of Pathology. 226: 7-16. PMID 22072542 DOI: 10.1002/Path.2995 |
0.493 |
|
| 2012 |
Wakimoto H, Mohapatra G, Kanai R, Curry WT, Yip S, Nitta M, Patel AP, Barnard ZR, Stemmer-Rachamimov AO, Louis DN, Martuza RL, Rabkin SD. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. Neuro-Oncology. 14: 132-44. PMID 22067563 DOI: 10.1093/Neuonc/Nor195 |
0.67 |
|
| 2012 |
Yip S, Cheang MCU, Kennecke HF. Use of gene set analysis (GSA) for molecular classification of responders and nonresponders to FOLFOX therapy in colorectal cancer (CRC). Journal of Clinical Oncology. 30: 3628-3628. DOI: 10.1200/Jco.2012.30.15_Suppl.3628 |
0.317 |
|
| 2012 |
Kozono D, Nitta M, Sampetrean O, Kimberly N, Kushwaha D, Merzon D, Ligon K, Zhu S, Zhu K, Kim TH, Kwon C, Becher O, Saya H, Chen CC, Donovan LK, ... ... Yip S, et al. LAB-STEM CELLS Neuro-Oncology. 14: vi142-vi152. DOI: 10.1093/Neuonc/Nos239 |
0.406 |
|
| 2011 |
Kennecke HF, Rahman M, Yip S, Woods R, Schaeffer D, Tai I. Effect of nab-rapamycin versus rapamycin in colorectal cancer cell lines and associations with KRAS and PI3K mutations. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e13532. PMID 28022696 DOI: 10.1200/Jco.2011.29.15_Suppl.E13532 |
0.32 |
|
| 2011 |
Lee AF, Yip S, Smith AC, Hayes MM, Nielsen TO, O'Connell JX. Low-grade fibromyxoid sarcoma of the perineum with heterotopic ossification: case report and review of the literature. Human Pathology. 42: 1804-9. PMID 21658743 DOI: 10.1016/J.Humpath.2011.01.023 |
0.355 |
|
| 2010 |
Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, Yang W, Heravi-Moussavi A, Giuliany R, Chow C, Fee J, ... ... Yip S, et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. The New England Journal of Medicine. 363: 1532-43. PMID 20942669 DOI: 10.1056/Nejmoa1008433 |
0.311 |
|
| 2010 |
Jansen M, Yip S, Louis DN. Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers. The Lancet. Neurology. 9: 717-26. PMID 20610347 DOI: 10.1016/S1474-4422(10)70105-8 |
0.61 |
|
| 2010 |
van Eekelen M, Sasportas LS, Kasmieh R, Yip S, Figueiredo JL, Louis DN, Weissleder R, Shah K. Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors. Oncogene. 29: 3185-95. PMID 20305695 DOI: 10.1038/Onc.2010.75 |
0.522 |
|
| 2010 |
Doucette TA, Kong L, Yang Y, Wei J, Wang J, Fuller GN, Heimberger AB, Rao G, Ajewung N, Kamnasaran D, Katz AM, Amankulor N, Squatrito M, Hambardzumyan D, Holland EC, ... ... Yip S, et al. Tumor Models (In Vivo/In Vitro) Neuro-Oncology. 12: iv130-iv136. DOI: 10.1093/Neuonc/Noq116.S20 |
0.53 |
|
| 2009 |
Quant EC, Silver M, Yip S, Ryg P, Provencher K, McCormack K, Louis DN, Betensky R, Nutt C, Batchelor TT. Case-control study of long-term survivors of glioblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e13021. PMID 27962816 DOI: 10.1200/Jco.2009.27.15_Suppl.E13021 |
0.665 |
|
| 2009 |
Gerstner ER, Yip S, Wang DL, Louis DN, Iafrate AJ, Batchelor TT. MGMT methylation status may predict survival in elderly patients with newly diagnosed glioblastoma (GBM). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e13023. PMID 27962794 DOI: 10.1200/Jco.2009.27.15_Suppl.E13023 |
0.478 |
|
| 2009 |
Gerstner ER, Yip S, Wang DL, Louis DN, Iafrate AJ, Batchelor TT. Mgmt methylation is a prognostic biomarker in elderly patients with newly diagnosed glioblastoma. Neurology. 73: 1509-10. PMID 19884580 DOI: 10.1212/Wnl.0B013E3181Bf9907 |
0.497 |
|
| 2009 |
Yip S, Miao J, Cahill DP, Iafrate AJ, Aldape K, Nutt CL, Louis DN. MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4622-9. PMID 19584161 DOI: 10.1158/1078-0432.Ccr-08-3012 |
0.727 |
|
| 2008 |
Yip S, Iafrate AJ, Louis DN. Molecular diagnostic testing in malignant gliomas: a practical update on predictive markers. Journal of Neuropathology and Experimental Neurology. 67: 1-15. PMID 18091559 DOI: 10.1097/Nen.0B013E31815F65Fb |
0.516 |
|
| 2003 |
Yip S, Aboody KS, Burns M, Imitola J, Boockvar JA, Allport J, Park KI, Teng YD, Lachyankar M, McIntosh T, O'Rourke DM, Khoury S, Weissleder R, Black PM, Weiss W, et al. Neural stem cell biology may be well suited for improving brain tumor therapies. Cancer Journal (Sudbury, Mass.). 9: 189-204. PMID 12952304 DOI: 10.1097/00130404-200305000-00007 |
0.349 |
|
| Show low-probability matches. |